The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.

Hepatitis B virus (HBV) infection is a leading risk factor for hepatocellular carcinoma (HCC). HBV integration into the host genome has been reported, but its scale, impact and contribution to HCC development is not clear. Here, we sequenced the tumor and nontumor genomes (>80× coverage) and transcriptomes of four HCC patients and identified 255 HBV integration sites. Increased sequencing to 240× coverage revealed a proportionally higher number of integration sites. Clonal expansion of HBV-integrated hepatocytes was found specifically in tumor samples. We observe a diverse collection of genomic perturbations near viral integration sites, including direct gene disruption, viral promoter-driven human transcription, viral-human transcript fusion, and DNA copy number alteration. Thus, we report the most comprehensive characterization of HBV integration in hepatocellular carcinoma patients. Such widespread random viral integration will likely increase carcinogenic opportunities in HBV-infected individuals.

[1]  Critical Roles of Nuclear Receptor Response Elements in Replication of Hepatitis B Virus , 2001, Journal of Virology.

[2]  A. Sparks,et al.  The mutation spectrum revealed by paired genome sequences from a lung cancer patient , 2010, Nature.

[3]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[4]  S. Poppema,et al.  The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin‐driven sprouting neovascularization , 2008, Hepatology.

[5]  M. Bouchard,et al.  Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. , 2011, Cancer letters.

[6]  R. Jordan,et al.  Molecular viral oncology of hepatocellular carcinoma , 2003, Oncogene.

[7]  Robert B. Hartlage,et al.  This PDF file includes: Materials and Methods , 2009 .

[8]  M. Sterneck,et al.  Clinical reactivation after liver transplantation with an unusual minor strain of hepatitis B virus in an occult carrier , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  Natarajan Ganesan,et al.  Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon , 2010, Cancer Cell International.

[10]  P. Kleihues,et al.  AXIN1 mutations but not deletions in cerebellar medulloblastomas , 2003, Oncogene.

[11]  Seunghee Lee,et al.  Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors. , 2008, Molecular endocrinology.

[12]  E. Birney,et al.  A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.

[13]  T. Okanoue,et al.  Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas , 2005, Gut.

[14]  Mulyanto,et al.  Analysis of the full‐length genomes of novel hepatitis B virus subgenotypes C11 and C12 in Papua, Indonesia , 2011, Journal of medical virology.

[15]  Takehide Asano,et al.  Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed‐lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma , 2008, Human mutation.

[16]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[17]  Serban Nacu,et al.  Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..

[18]  M. Chen,et al.  Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation , 1993, Molecular and cellular biology.

[19]  T. Okanoue,et al.  Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging , 2001, Oncogene.

[20]  Yoshiki Murakami,et al.  Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene , 2003, Oncogene.

[21]  F. Zoulim,et al.  Hepatitis B virus induced hepatocellular carcinoma. , 2009, Cancer letters.

[22]  R. Roeder,et al.  A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4 , 2009, Proceedings of the National Academy of Sciences.

[23]  S. Gabriel,et al.  Advances in understanding cancer genomes through second-generation sequencing , 2010, Nature Reviews Genetics.

[24]  Hidenori Ojima,et al.  High-resolution characterization of a hepatocellular carcinoma genome , 2011, Nature Genetics.

[25]  Tom Royce,et al.  A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.

[26]  Ronald A. DePinho,et al.  Hepatocellular carcinoma pathogenesis: from genes to environment , 2006, Nature Reviews Cancer.

[27]  Robert W. Williams,et al.  The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival , 2008, Clinical & Experimental Metastasis.

[28]  A. Dejean,et al.  Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Bréchot,et al.  Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). , 2000, Seminars in cancer biology.

[30]  I. Tomlinson,et al.  Colorectal cancer and genetic alterations in the Wnt pathway , 2006, Oncogene.

[31]  D. Lavanchy,et al.  Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures , 2004, Journal of viral hepatitis.

[32]  N. Carter,et al.  Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.

[33]  P Michielsen,et al.  Viral hepatitis B and hepatocellular carcinoma. , 2011, Acta gastro-enterologica Belgica.

[34]  S. Boyault,et al.  Differential effects of inactivated Axin1 and activated β-catenin mutations in human hepatocellular carcinomas , 2007, Oncogene.

[35]  S. Litwin,et al.  Clonal Expansion of Normal-Appearing Human Hepatocytes during Chronic Hepatitis B Virus Infection , 2010, Journal of Virology.

[36]  A. Raney,et al.  Characterization of the hepatitis B virus major surface antigen promoter hepatocyte nuclear factor 3 binding site. , 1997, The Journal of general virology.